Disclaimer: this software uses AI to aggregate and filter content. Please double-check sources before putting info to action.
📰 News Media
- 💉 [Baltimore, MD] The Ruthless Efficiency of Ultrapotent Street Drugs - nytimes.com
- 🧪 [Knoxville, Tennessee] His Research on Pregnant Opioid Users Was Widely Celebrated. Auditors and Experts Found Major Flaws. - propublica.org
- 🧠 [Houston, TX] Ibogaine By David Dardashti Initiates Exploratory Research Framework into Postpartum Depression, Minimal Dosing, and Collaborative Aftercare Mandates - forwardtimes.com
- 🚨 [National] Fentanyl investigations and seizures dropped during Trump’s immigration crackdown, federal watchdog says - cnn.com
- 💰 [National] 10 SUD Providers Sue Cigna for $12.7M in Underpayments - bhbusiness.com
🗣️ Social Pulse
Lived/Living Experience
- No posts found today.
Innovation
- 🧠 Useful memory is the product. Unnecessary memory is the risk. An agent that can track recovery trends across nights, notice when habits are drifting, and hand a coherent plan to the next specialist is genuinely more... - @onchainMML on X
- 📱 Rehab costs $30k/month. Relapse rates hit 60%. An AI agent can now offer 24/7, continuous support. Access inverted. Accountability? Gone. 👀 Addiction treatment was always gated by price + scarcity. Professionals... - @ShinkaIoT on X
Opposition Views
- No posts found today.
🏙 City Updates
- No recent City Updates found.
📚 Academic Research
- 💊 A Clinic-Level Intervention May Promote Methadone Patients’ Consistent Daily Adherence to Their Dosing Schedules - Substance Use & Addiction Journal - 2026-08-25 - doi.org
- 🚨 Health Harms Associated With Forced Displacements Among People Who Use Drugs in San Francisco, California - Substance Use & Addiction Journal - 2026-08-25 - doi.org
- 🚭 A novel harm reduction approach for oncology outpatients who smoke and refuse traditional tobacco treatment: a protocol for a type 1 hybrid effectiveness-implementation trial - Addiction Science & Clinical Practice - 2026-08-25 - doi.org
⚖️ Law & Policy
- No hits in Law and Policy today.
💸 Funding
Current
- Deadline Approaching🚑 Office of National Drug Control Policy - Nonfatal Overdoses in Emergency Departments: Bridging Patient Characteristics, Biospecimen Toxicology, and Drug Supply Composition - Deadline: Aug 31, 2026
- 💊 Bureau of Justice Assistance - BJA FY 2026 Comprehensive Opioid, Stimulant, and Substance Use Site-Based Program - Deadline: Sep 24, 2026
- 💊 Bureau of Justice Assistance - BJA FY 2026 Second Chance Act Family-Based Substance Use Disorder Treatment Program - Deadline: Sep 24, 2026
- 🔬 National Institutes of Health - Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed) - Deadline: Sep 30, 2026
- 🔬 National Institutes of Health - Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional) - Deadline: Aug 21, 2028
- 🔬 National Institutes of Health - Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) - Deadline: Sep 25, 2028
- 🔬 National Institutes of Health - HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional) - Deadline: Feb 9, 2029
- 🩺 Hearst Foundations - Health - Hearst Foundations Health (year-round, rolling applications) - Minimum grant size is $100,000. - Deadline: Year-round, rolling application; there are no deadlines.
- 🤝 Hearst Foundations - Social Service - Hearst Foundations — Social Service (year-round rolling grant applications) - Minimum grant size is $100,000. - Deadline: Year-round, rolling application; there are no deadlines.
- 💡 Smart Family Fund - First time grants ranging from $25,000 to $100,000. - Deadline: Open pitch
📣 Activism
- No activism updates found.